The FDA has cleared two new blood tests for Alzheimer’s disease, Roche’s Elecsys pTau217 and C2N Diagnostics’ PrecivityAD2, which could help support earlier Alzheimer’s disease detection.
Continue reading at Medical News Today.

The FDA has cleared two new blood tests for Alzheimer’s disease, Roche’s Elecsys pTau217 and C2N Diagnostics’ PrecivityAD2, which could help support earlier Alzheimer’s disease detection.
Continue reading at Medical News Today.